BioCentury
ARTICLE | Financial News

Cell Innovation Partners L.P. financial update

October 6, 2014 7:00 AM UTC

ReproCell markets induced pluripotent stem cell (iPSC)-derived cardiomyocytes, neurons and hepatocytes for drug discovery. The company also markets primary cells for diabetes research and media and re...